The Securities and Exchange Commission announced on May 18, 2026 that it has rescinded Rule 202.5(e), ending the agency’s long-standing practice of requiring settling parties not to publicly deny the SEC’s allegations. The change marks a notable shift in enforcement policy and is likely to alter the leverage, messaging, and negotiation dynamics in SEC resolutions going forward.

For decades, the SEC’s settlement framework allowed defendants to resolve cases without admitting wrongdoing in many instances, but it also prohibited them from later publicly disputing the agency’s allegations.

The Justice Department’s Antitrust Division has proposed a settlement with Agri Stats to resolve allegations that the company facilitated unlawful information-sharing among competing meat processors. The case, pending in the District of Minnesota, centers on claims that Agri Stats collected and distributed detailed price, output, and cost data in ways that allowed poultry, pork, and turkey producers to coordinate behavior rather than compete independently.

According to the government, the proposed settlement is designed to restore competitive conditions in protein markets that affect both upstream producers and downstream purchasers.

Shutterstock has agreed to pay $35 million to resolve Federal Trade Commission allegations that it used deceptive subscription and cancellation practices, adding to a growing line of enforcement actions targeting so-called “negative option” marketing. According to the FTC, Shutterstock obscured important terms tied to annual subscription and content-pack plans and made it harder for customers to cancel than to sign up.

While the dollar amount is notable, the broader significance lies in what the case signals about the FTC’s enforcement priorities.

Monday’s legal news cycle was notable less for a single blockbuster ruling than for a concentrated burst of federal enforcement activity that reinforces a broader trend: the Department of Justice continues to use press announcements, charging decisions, and coordinated policy moves to signal aggressive expectations around corporate compliance, individual accountability, and cross-agency enforcement.

For legal professionals, that matters because DOJ activity often functions as an early warning system.

The Federal Trade Commission has announced a $35 million settlement with Shutterstock over allegations that the company used deceptive subscription practices, including misleading consumers about billing terms and making cancellation unnecessarily difficult. The action is the latest in the FTC’s broader campaign against so-called “dark patterns” — interface designs or workflows that steer consumers into purchases, renewals, or ongoing charges they may not have knowingly agreed to.

At a high level, the case reflects a familiar enforcement theory: regulators are focusing not just on what companies disclose, but on how those disclosures are presented and whether consumers can realistically avoid or end recurring charges.

The U.S. Supreme Court has granted emergency relief that keeps nationwide access to mifepristone by telemedicine and mail in place while litigation over the FDA’s regulatory approach moves forward. The order does not resolve the merits, but it preserves the current framework for prescribing and distributing the abortion pill for now — an important signal in a dispute with consequences well beyond reproductive health.

The underlying case challenges FDA decisions that allowed broader access to mifepristone, including dispensing through the mail and via telehealth.

The Southern District of New York has unsealed multiple criminal indictments highlighting two enforcement priorities that continue to draw sustained federal attention: firearms trafficking with cross-border implications and bias-motivated violence. Among the newly announced cases are charges against Malik Bromfield, Faizan Ali, and Kamal Salman tied to the transport of dozens of firearms allegedly intended for attempted smuggling into Canada, as well as a separate hate-crime indictment against Shorai Moore.

While these matters are unlikely to reshape doctrine in the way a major appellate ruling might, they are still significant for practitioners because they reflect where federal investigators and prosecutors are investing resources.

The U.S. Court of Appeals for the Federal Circuit has temporarily paused a U.S. Court of International Trade ruling that would have halted collection of tariffs imposed under President Trump’s trade program, preserving the status quo while appellate review moves forward. The order keeps the tariffs in place for now in a closely watched dispute over the scope of presidential trade authority and the limits of emergency-based executive action.

The litigation includes challenges brought by states and private importers, including State of Oregon v. Trump, now before the Federal Circuit.

A federal judge in Washington, D.C., is signaling that a proposed SEC settlement tied to disclosures around Elon Musk’s earlier Twitter stock purchases may face a tougher path than the parties expected. In a recent hearing, the court reportedly identified “red flags” in the proposed resolution, raising the possibility that the deal will not be approved in its current form.

That alone makes the matter worth watching.

Federal prosecutors in Boston and the SEC have unsealed a closely watched insider-trading case alleging that confidential merger information was funneled from lawyers at elite law firms into a wider trading network. The government’s allegations center on Nicolo Nourafchan and Robert Yadgarov, and reportedly tie the flow of nonpublic deal information to attorneys associated with Goodwin Procter and Latham Watkins.

What makes this case stand out is not just the scale of the alleged trading scheme, but the source of the information.

Elon Musk has settled the SEC’s lawsuit over the timing of his 2022 disclosures about his initial Twitter stake, resolving one of the agency’s most closely watched beneficial-ownership reporting cases. Under the reported deal, a trust will pay a $1.5 million civil penalty, bringing to a close a dispute that tested how aggressively the SEC would pursue delayed Schedule 13D-style disclosures in a headline-making transaction.

The case centered on allegations that Musk did not timely disclose that he had crossed the 5% ownership threshold in Twitter stock, a milestone that can trigger federal reporting obligations for investors acquiring significant positions in public companies.

A federal appeals fight scheduled for Thursday put an unusual and consequential question before the D.C. Circuit: how far a president or executive branch may go in penalizing private law firms based on the clients they represent or positions they take in politically charged matters.

According to reporting on the matter, former President Donald Trump is seeking appellate relief tied to efforts aimed at punishing major law firms.

The U.S. Supreme Court has handed climate plaintiffs a meaningful procedural win, ruling that Enbridge could not remove a climate-related suit to federal court after the statutory deadline had passed. The Court rejected Enbridge’s argument that the removal clock under 28 U.S.C. § 1446(b)(1) could be equitably tolled, leaving the case where it began: state court.

That may sound like a narrow civil-procedure dispute, but for litigators following energy and environmental cases, it is a consequential one.

One of the most closely watched AI-adjacent copyright disputes in legal tech is moving deeper into the appellate phase. Thomson Reuters and Ross Intelligence are now before the Third Circuit in Thomson Reuters Enterprise Centre GmbH, et al v. Ross Intelligence Inc, a case that has become a bellwether for how courts may treat the use of proprietary legal content in building competing research tools.

The dispute stems from allegations that Ross used Thomson Reuters’ Westlaw headnotes and related editorial material to train or develop its legal research platform without authorization.

The U.S. Supreme Court has temporarily preserved broader access to mifepristone, blocking a lower-court ruling that would have allowed Idaho to enforce restrictions affecting the abortion pill while the litigation moves forward. The order does not resolve the merits, but it keeps the status quo in place and signals that the justices remain deeply engaged in how post-Dobbs abortion disputes intersect with federal drug regulation.

The immediate legal question is narrower than the broader political debate: how far can a state go in limiting access to an FDA-approved drug when that access is also shaped by federal regulatory decisions? That tension has become a central battleground since Dobbs, especially where states seek to impose restrictions that may conflict with the FDA’s approval framework, labeling decisions, and distribution rules.

For litigators, the Court’s temporary intervention is a reminder that emergency relief in reproductive-rights cases can effectively determine access on the ground long before a final merits ruling.